TL;DR
This paper critically reviews the use of GANs for data augmentation and anonymization in skin-lesion analysis, highlighting their limited effectiveness mainly on out-of-distribution test sets and cautioning their medical application.
Contribution
It provides a comprehensive evaluation of GAN-based methods in skin-lesion analysis, emphasizing the need for careful consideration of their limitations and risks.
Findings
GANs improve performance mainly on out-of-distribution test sets
GAN-based anonymization shows limited benefits for in-distribution data
Caution is advised due to costs and potential risks of GAN deployment in medical settings
Abstract
Despite the growing availability of high-quality public datasets, the lack of training samples is still one of the main challenges of deep-learning for skin lesion analysis. Generative Adversarial Networks (GANs) appear as an enticing alternative to alleviate the issue, by synthesizing samples indistinguishable from real images, with a plethora of works employing them for medical applications. Nevertheless, carefully designed experiments for skin-lesion diagnosis with GAN-based data augmentation show favorable results only on out-of-distribution test sets. For GAN-based data anonymization where the synthetic images replace the real ones favorable results also only appear for out-of-distribution test sets. Because of the costs and risks associated with GAN usage, those results suggest caution in their adoption for medical applications.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
